Skip to main content
Top

Familial Cancer

Issue 2/2009

Content (11 Articles)

Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore

Hui-Ling Yap, Wei-Shieng Chieng, Jasmine Rui-Chen Lim, Robert Seng-Cheong Lim, Ross Soo, Jiayi Guo, Soo-Chin Lee

Intussusception in the adult: an unsuspected case of Peutz–Jeghers syndrome with review of the literature

Jason D. Fraser, Steven E. Briggs, Shawn D. St. Peter, Giovanni De Petris, Jacques Heppell

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening

Wai Tong Ng, Cheuk Wai Choi, Michael C. H. Lee, Siu Hong Chan, Tsz Kok Yau, Anne W. M. Lee

Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination

Sana Aissi-Ben Moussa, Amel Moussa, Tonio Lovecchio, Nadia Kourda, Taoufik Najjar, Sarra Ben Jilani, Amel El Gaaied, Nicole Porchet, Mohamed Manai, Marie-Pierre Buisine

Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women

Tal Distelman-Menachem, Tal Shapira, Yael Laitman, Bella Kaufman, Frida Barak, Sean Tavtigian, Eitan Friedman

SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women

Shimrit Cohen, Yael Laitman, Bella Kaufman, Roni Milgrom, Uri Nir, Eitan Friedman

High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers

Eli Marie Grindedal, Ignacio Blanco, Astrid Stormorken, Lovise Maehle, Neal Clark, Sara González, Gabriel Capella, Hans Vasen, John Burn, Pål Møller

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment

Paul Bennett, Clare Wilkinson, Jim Turner, Rhiannon Tudor Edwards, Barbara France, Gethin Griffin, Jonathon Gray

Concordant colon tumors in monozygotic twins previously treated for prostate cancer

Arnoud Templeton, Giancarlo Marra, Emanuele Valtorta, Karl Heinimann, Hansjakob Müller, Dieter Köberle, Silke Gillessen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine